Project Details
Description
A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart in Adults With Dermatomyositis
| Status | Active |
|---|---|
| Effective start/end date | 6/24/25 → 4/17/27 |
Funding
- ARGENX BV
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.